We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.05B
AUM Growth
+$688M
(+11%)
Cap. Flow
+$306M
Cap. Flow
% of AUM
4.35%
Top 10 Holdings %
Top 10 Hldgs %
15.99%
Holding
1,149
New
136
Increased
453
Reduced
359
Closed
174
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$40.4M |
| 2 |
Amazon
AMZN
|
+$35M |
| 3 |
TJX Companies
TJX
|
+$34.6M |
| 4 |
Phillips 66
PSX
|
+$33.1M |
| 5 |
Mastercard
MA
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$31.7M |
| 2 |
Cigna
CI
|
+$27.3M |
| 3 |
Meta Platforms (Facebook)
META
|
+$21.6M |
| 4 |
JPMorgan Chase
JPM
|
+$21M |
| 5 |
Marvell Technology
MRVL
|
+$20.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.29% |
| 2 | Financials | 17.18% |
| 3 | Consumer Discretionary | 12.24% |
| 4 | Industrials | 11.66% |
| 5 | Healthcare | 10.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BELFB
626
Bel Fuse Inc Class B
BELFB
$3.88B
| $1.16M | 0.02% |
43,677
+12,950
| +42% | +$323K |
|
627
STAAR Surgical
STAA
$1.16B
| $1.15M | 0.02% |
23,992
-6,580
| -22% | -$269K |
|
628
Minerva Neurosciences
NERV
$188M
| $1.14M | 0.02% |
11,309
+4,963
| +78% | +$373K |
|
629
Larimar Therapeutics
LRMR
$416M
| $1.13M | 0.02% |
8,074
-217
| -3% | -$26.3K |
|
630
NextEra Energy
NEE
$187B
| $1.13M | 0.02% |
26,880
+120
| +0.4% | +$5.11K |
|
631
Norfolk Southern
NSC
$78.8B
| $1.12M | 0.02% |
6,220
-1,300
| -17% | -$222K |
|
632
Healthpeak Properties
DOC
$15.4B
| $1.1M | 0.02% |
41,920
-155,260
| -79% | -$4.08M |
|
633
Booking.com
BKNG
$138B
| $1.1M | 0.02% |
13,850
-90,025
| -87% | -$7.09M |
|
634
Andersons Inc
ANDE
$2.65B
| $1.08M | 0.02% |
+28,673
| New | +$1.08M |
|
|
CTRL
635
DELISTED
Control4 Corporation
CTRL
| $1.08M | 0.02% |
31,450
-640
| -2% | -$19.7K |
|
|
NSTG
636
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.06M | 0.02% |
59,573
-37,884
| -39% | -$553K |
|
|
LTRPA
637
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $1.05M | 0.02% |
71,055
+31,155
| +78% | +$493K |
|
|
WRD
638
DELISTED
WildHorse Resource Development
WRD
| $1.05M | 0.02% |
+44,590
| New | +$957K |
|
|
AAMI
639
Acadian Asset Management
AAMI
$2.88B
| $1.05M | 0.01% |
84,665
-212,308
| -71% | -$2.79M |
|
|
XHR
640
Xenia Hotels & Resorts
XHR
$1.98B
| $1.05M | 0.01% |
44,234
+12,600
| +40% | +$304K |
|
641
Park-Ohio Holdings
PKOH
$554M
| $1.04M | 0.01% |
27,137
+5,287
| +24% | +$205K |
|
|
CMRX
642
DELISTED
Chimerix, Inc.
CMRX
| $1.04M | 0.01% |
266,601
+19,685
| +8% | +$83.8K |
|
|
HIBB
643
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $1.03M | 0.01% |
54,983
+5,300
| +11% | +$120K |
|
644
Cytokinetics
CYTK
$11B
| $1.03M | 0.01% |
104,436
+16,038
| +18% | +$129K |
|
645
Fabrinet
FN
$17.1B
| $1.02M | 0.01% |
+22,050
| New | +$947K |
|
|
HTLF
646
DELISTED
Heartland Financial USA, Inc.
HTLF
| $1.02M | 0.01% |
17,520
+4,140
| +31% | +$246K |
|
647
GoPro
GPRO
$116M
| $1.02M | 0.01% |
141,100
+9,800
| +7% | +$62.7K |
|
|
BLCM
648
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $1.02M | 0.01% |
16,492
+4,452
| +37% | +$301K |
|
649
Cummins
CMI
$91.7B
| $1.01M | 0.01% |
6,940
-38,670
| -85% | -$5.44M |
|
650
Seres Therapeutics
MCRB
$48.1M
| $989K | 0.01% |
6,514
-460
| -7% | -$74.4K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2018 Portfolio in Review
As of Q3 2018, Jacobs Levy Equity Management held 1,149 positions worth $7.05B, up 11% from $6.36B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $306M of net new capital in Q3 2018, opening 136 new positions and adding to 453 existing holdings. Its largest new stake was TJX Companies: 673,440 shares worth $37.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Eli Lilly, an estimated $31.7M trimmed.
- Jacobs Levy Equity Management's largest Q3 2018 buy was TJX Companies: 673,440 shares worth $37.7M.
- Jacobs Levy Equity Management added most to Alphabet (Google) Class C in Q3 2018, an estimated $40.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2018 reduction was Eli Lilly, cutting an estimated $31.7M.
- Jacobs Levy Equity Management fully exited Dun & Bradstreet in Q3 2018, selling an estimated $17.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $7.05B portfolio in Q3 2018.
- Jacobs Levy Equity Management opened 136 new positions and closed 174 in Q3 2018.
- Jacobs Levy Equity Management's portfolio value rose 11% quarter-over-quarter to $7.05B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2018, filed 14 Nov 2018.